To Access the Effects of Mucositis in Adults With Dental Implants
NCT ID: NCT01072201
Last Updated: 2010-10-05
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
60 participants
INTERVENTIONAL
2007-06-30
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total toothpaste
Triclosan/copolymer/fluoride toothpaste
Triclosan and Fluoride
Brush twice daily
Ultrabrite toothpaste
Fluoride Toothpaste
Fluoride
Brush twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triclosan and Fluoride
Brush twice daily
Fluoride
Brush twice daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability for the six-month duration of the clinical research study.
* Good general health.
* Subjects who have lost teeth for periodontal disease reasons and who have been restored with implants.
* Minimum of 5 remaining teeth and a minimum of 2 implants.
* Initial evaluation of the gingival and peri-implant mucosal tissues by determining full mouth bleeding on probing.
* Initial plaque evaluation by determining full mouth presence/absence of plaque.
* Signed Informed Consent Form.
Exclusion Criteria
* Untreated periodontal disease (purulent exudate, tooth mobility, and/or extensive loss or periodontal attachment or alveolar bone).
* Carious lesions requiring immediate restorative treatment.
* Uncontrolled Diabetes
* Use of antibiotics any time during the one month prior to entry into the study.
* Untreated peri-implantitis.
* Participation in any other clinical research study or test panel within the three months prior to entry into the study.
* Pregnant women or women who are breast feeding.
* History of allergies to personal care/consumer products or their ingredients.
* Medical condition which prohibits not eating/drinking for up to 2 hours.
* Current alcohol or drug abuse.
* Systemic or local disease conditions that would compromise post-operative healing.
* Regular use of anti-inflammatory drugs.
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Colgate Palmolive
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Colgate Palmolive
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per Ramberg, DDS
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ariminum Research & Dental Education Center
Rimini, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRO-0107-PERIO-MUC-ITA-PC
Identifier Type: -
Identifier Source: org_study_id